Clinical Trial Detail

NCT ID NCT02350673
Title A Study of Intravenous RO6895882 and MPDL3280A Combination in Patients With Locally Advanced and/or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

Therapies

Cergutuzumab amunaleukin

Atezolizumab

Age Groups: adult

No variant requirements are available.